chr5-129461122-C-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_133638.6(ADAMTS19):āc.112C>Gā(p.Arg38Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00281 in 1,420,116 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R38L) has been classified as Uncertain significance.
Frequency
Consequence
NM_133638.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADAMTS19 | NM_133638.6 | c.112C>G | p.Arg38Gly | missense_variant | 2/23 | ENST00000274487.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADAMTS19 | ENST00000274487.9 | c.112C>G | p.Arg38Gly | missense_variant | 2/23 | 1 | NM_133638.6 | P1 | |
ADAMTS19 | ENST00000505791.5 | c.91+640C>G | intron_variant, NMD_transcript_variant | 3 | |||||
ADAMTS19-AS1 | ENST00000661962.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00164 AC: 249AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00112 AC: 71AN: 63658Hom.: 0 AF XY: 0.000892 AC XY: 33AN XY: 36990
GnomAD4 exome AF: 0.00295 AC: 3739AN: 1267856Hom.: 5 Cov.: 30 AF XY: 0.00276 AC XY: 1723AN XY: 623788
GnomAD4 genome AF: 0.00164 AC: 249AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.00134 AC XY: 100AN XY: 74448
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 23, 2021 | The c.94C>G (p.R32G) alteration is located in exon 2 (coding exon 2) of the ADAMTS19 gene. This alteration results from a C to G substitution at nucleotide position 94, causing the arginine (R) at amino acid position 32 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ADAMTS19-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 28, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at